Microarrays Market Size, Share, Regional Growth, 2026-2034
- jhon smith
- 2 days ago
- 3 min read
Market Overview
According to fortune business insights, The global microarrays market size was valued at USD 6.85 billion in 2025. The market is projected to grow from USD 7.25 billion in 2026 to USD 12.72 billion by 2034, exhibiting a CAGR of 7.27% during the forecast period. North America dominated the microarrays market with a market share of 43.35% in 2025.
The analysis shows that top companies are investing more in microarrays because of the rising demand for these tools in genomics research and the need for innovative therapies. For example, the increasing global burden of chronic and infectious diseases necessitates enhanced genetic profiling tools for earlier diagnosis and personalized healthcare. This trend indicates a strong demand for microarray technologies worldwide.
Major Players Profiled in the Market Report:
Agilent Technologies Inc. (U.S.)
Thermo Fisher Scientific Inc. (U.S.)
Bio Rad Laboratories Inc. (U.S.)
Illumina Inc. (U.S.)
Arrayit Corporation (U.S.)
CDI Labs (Puerto Rico)
Creative Biolabs (U.S.)
Creative Proteomics (U.S.)
Merck KGaA (Germany)
CD Genomics (U.S.)
Segments
High Demand in Diagnostics to Propel Products Segment Growth
Based on offering, the market is divided into products and software & services. The products segment holds the largest market share owing to the growing demand from research institutions and labs, coupled with increasing adoption in diagnostics and drug development.
High Usage in Genomics to Drive DNA Microarray Segment Expansion
By type, the market is categorized into DNA microarray, protein microarray, tissue microarray, and others. The DNA microarray segment is leading the market due to its widespread applications in genotyping and expression studies, cost-effectiveness, and high gene monitoring capacity.
Increasing Focus on Genomics Research to Dominate the Market
Based on application, the market is segmented into drug discovery & development, diagnostics, research, and others. The research segment holds the largest market share, as microarrays are a powerful tool for gene expression profiling, comparative genomics, disease diagnosis, and drug discovery.
Early Adoption by Institutions to Propel Research & Academic Institutes Segment Growth
Based on end-user, the market is segmented into pharmaceutical & biotechnology companies, research & academic institutes, diagnostic laboratories, and others. The research & academic institutes segment holds the largest market share owing to early adoption, increasing government support for R&D, and a large installed base.
Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
Report Coverage
The report offers:
Major growth drivers, restraining factors, opportunities, and potential challenges for the market.
Comprehensive insights into regional developments.
List of major industry players.
Key strategies adopted by the market players.
The latest industry developments include product launches, partnerships, mergers, and acquisitions.
Drivers & Restraints
Rising Incidence of Chronic and Infectious Diseases to Propel Market Growth
The rapid increase in the global burden of chronic and infectious diseases has raised the demand for advanced molecular profiling tools. Microarrays enable accurate identification of pathogens and genetic predispositions, allowing for faster diagnosis, targeted treatment, and personalized healthcare, boosting the microarrays market growth.
However, the increasing adoption of alternative advanced technologies such as Next-Generation Sequencing (NGS) and the high cost of microarray instrumentation and maintenance may hamper market growth.
Regional Insights
High R&D Spending in the U.S. Propels Market Growth in North America
North America holds the dominant microarrays market share and is projected to experience growth during the forecast period. The region’s growth is attributed to high R&D spending in the biotechnology and pharmaceutical industries, strong genomics research, and an established healthcare infrastructure. The North American market was valued at USD 2.97 billion in 2025.
Asia Pacific is one of the major regions in the market. The growth is attributed to increasing investments in biotechnology and genomics research, along with a rising focus on precision medicine in countries such as China and India.
Competitive Landscape
Broad Product Portfolios and Strong Geographic Presence to Propel Market Growth
The market features prominent players like Illumina Inc., Thermo Fisher Scientific Inc., and Agilent Technologies Inc. These leading companies are accelerating growth through broad product portfolios, global commercial footprints, and high penetration among end users. Their proactive approach to innovation and expansion continues to fuel the market’s momentum.
Key Industry Development
March 2025: UNSW Sydney announced their first Applied Biosystems Axiom PangenomiX Array project for genotyping hundreds of thousands of genetic variants.
December 2023: Spectrum Solutions acquired Alimetrix, Inc., and Microarrays, Inc., for expansion of its lab capabilities and testing capabilities.
October 2023: Sengenics Corporation LLC introduced the i-ome discovery platform, a comprehensive protein microarray platform analyzing over 1,800 autoantigens.
Comments